• Narmadatech: Known for Designing The Best and Highly-Featured Healthcare Websites - Launching a healthcare website often becomes a daunting process for those, who lack the required expertise and skills. Do you also own a healthcare business and intending to have the best healthcare website design for the same? If you do, then it is the time to get your healthcare website designed by creative minds. There are some companies that offer web design services for healthcare businesses, but NarmadaTech is the best among all. All the website designers at NarmadaTech work dedicatedly to deliver the best results in terms of professional, easy-to-access and responsive web design. Regardless of the business type, whether it is about the hospital or a clinic, their team of skilled web designers creates the best design for your healthcare website that exceeds all your demands. They also welcome your ideas or suggestions if you have to make your website customized. Benefits of corporate healthcare website designed from NarmadaTech are: Ease of Use: As they are trusted web designing company in Indore, they always keep themselves updated with the latest website design trends for healthcare web designing. That's the reason, the healthcare websites created by them have drag-and-drop functionality and many unique features. Niche-Specific Templates: If you need a medical website with amazing features, then NarmadaTech is one of the top solutions for this purpose. They make use of many impressive medical templates that can be used for medical centers, private medical clinic and for medical specialists such as dentists, nutrition experts, psychiatrists, psychologists etc. Customized Web Design: They allow you to customize your web design as per your business, location, expertise and other factors. With the help of powerful design customization tools and templates, they can create the fully-customized, responsive and easy-to-access website that meets all your business demands. Concluding this, if you want to have a highly functional, visually-attractive and quality medical websites design, then opt for the website design services of NarmadaTech. (Added: Mon Jan 14 2019 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• Collagen Market: Marine Collagen to Gain Maximum Prominence - The rising use of collagen in medical devices and drug delivery systems, increased preference for minimally invasive technologies, and the effectiveness in wound healing are expected to be some of the key factors driving the global demand for collagen in the coming years. Easy availability of a number of collagen sources and the low antigenicity of the material grant collagen an important position in a number of industries such as pharmaceuticals, food and beverages, and cosmeceuticals. Read Report Overview: https://www.transparencymarketresearch.com/collagen-market.html The high and rising demand for a variety of collagen products in the field of wound healing will play a major role in the overall development of the collagen market in the next few years, states TMR in its report. The high demand for a biodegradable material in the wound healing sector will be due to the rising prevalence of a number of chronic diseases such as numerous cancers and diabetes. The rising population of obese and geriatric people across the globe will also be a major end-use demographic for the collagen market. Collagen supplements for obese and elderly, whose bodies have a tendency of producing decreased levels of collagen, will be the primary driver of collagen market in the near future. Transparency Market Research points that the global collagen market will expand at a 9.4% CAGR over the period between 2015 and 2023. The market, which had a valuation of US$4.13 bn in 2014, is projected to rise to US$9.37 bn by 2023. Presently, bovine and porcine sources are amongst the leading sources of collagen used across a number of application areas. Bovine collagen, one of the largest industrial sources of collagen, accounted for a 30 kilo tons of collagen in the global market in 2014. Porcine collagen, on the other hand, accounted for a 27.4 kilo tons of the globe’s overall collagen market in the same year. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10460 However, the global usage of collagen from both these sources is expected to witness slight decline over the period between 2015 and 2023. Factors affecting the overall consumption of collagen produced from these sources will be the concerns regarding disease transmission, in the case of bovine collagen, and cultural impact and allergic reactions, in the case of porcine collagen. As a result, marine collagen, the collagen source considered to be the safest among all possible collagen sources, is expected to witness the highest rise in consumption on a global front. The market for marine collagen is expected to rise at the highest CAGR of 11.6% from 2015 to 2023 in terms of volume. North America and Europe are presently the leading regional markets for collagen and collagen products owing to the high level of awareness about the several benefits of these products among the population. The presence of high-end manufacturing capabilities and a constant rise in application areas have also majorly contributed to the flourishing market for collagen in these regions in the past. North America and Europe held a combined share of over 60% in the global collagen market in 2014. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10460 However, Asia Pacific will emerge as the most promising region for the global collagen market over the period between 2015 and 2023. The region is home to the largest number of people aged more than 60 years, numbers which are expected to rise at a rapid pace in the next few years. In addition to this, the region has witnessed an increased level of involvement of government bodies towards raising the awareness regarding the health benefits of collagen in the past few years. Technological advancements in the Asia Pacific collagen market, leading to an increased manufacturing capacity, has also made Asia Pacific a lucrative regional market for collagen. Over 2015 to 2023, the collagen market in Asia Pacific will rise at the highest CAGR of 10.7%. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 14 2019 Hits: 48 Rating: 0.00 Votes: 0) Rate It

• Pipettes and Accessories Market Outlook,Opportunity Analysis And Top Companies - The global pipettes and accessories market size was valued at US$ 1.3 billion in 2017 and is expected to witness a CAGR of 4.0% over the forecast period (2018 – 2026). Pipettes are used in biotechnology, pharmaceutical, and chemical laboratories in order to transfer certain volume of liquids. Micropipettes are important in molecular biology experiments, which require microliter amounts of solutions whereas serological pipettes are used in microbiology laboratories to prepare cell cultures that require media preparations of milliliter volumes. Volume transfers with sterile cultures and solutions using instruments such as micropipettes and serological pipettes are one of several types of routine techniques performed in a laboratory. Pipette designs such as electronic pipetting, ultralight pipettes, plungers positions in more user-friendly configurations, and reducing frictional forces help in reducing strain. Increasing research and development in the field of pharmaceuticals and biotechnology due to high prevalence of infectious diseases and cancer are the major factors driving the pipettes and accessories market growth. According to 2012 European Union Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sectors represented 17.7% of business R&D expenditure in the world. Pharmaceutical companies are increasingly focusing on conducting research and development activities as well as outsourcing such activities to academic and private research institutes. This in turn is increasing demand for liquid handling systems such as pipettes. Pharmaceutical companies are also increasingly outsourcing their research activities to privately-owned Contract Research Organizations (CRO) to maintain their presence in the growing pharmaceutical and biotechnology market. For instance, in May 2018, Ritter Pharmaceuticals, Inc., a manufacturer of novel therapeutic products entered into an agreement with Medpace, a CRO to conduct the first of two pivotal Phase 3 clinical trials for RP-G28 among patients with lactose intolerance. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2322 Pipettes and Accessories Market Restraints Pipettes are extensively used for various applications and are thus exposed to various types of reagents and specimens. They can introduce quality-specific concerns regarding precision and accuracy and can also lead to safety risks, particularly while working with hazardous chemicals or specimens with a high infection risk. Furthermore, high cost of electronic pipettes can be a negative factor for the market growth. For instance, the cost of the Xplorer plus electronic single channel pipette with charging adapter is around US$ 1000. This product may not be affordable for several laboratories due to its high price. However, manual pipettes tend to be more economical, though they produce greater variability, particularly for highly sensitive or expensive pipetting applications. Pipettes and Accessories Market - Regional Insights On the basis of region, the global pipettes and accessories market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the largest market for biotechnology and pharmaceutical research and manufacturing and therefore, demand for pipettes and accessories is the highest in the region. According to a study published by the International Trade Administration in 2016, the U.S. is the major hub for drug manufacturing and is expected to grow considerably in future. Asia Pacific pipettes and accessories market is expected to witness significant growth over the forecast period. This is owing to increasing clinical trials from biopharmaceutical industry in the region due to easy patient recruitment and availability of skilled professionals to conduct research experiments. This in turn leads to increasing number of research laboratories being set up in the region, thereby propelling demand for pipettes and accessories. For instance, in March 2017, Herbalife Company associated with Syngene established a new research and development lab at Bangalore, India. According to the India Brand Equity Foundation June 2018 report, Government of India has reduced the approval time for new facilities to propel investments for drug manufacturers under the ‘Pharma Vision 2020’. Such initiatives are expected to attract foreign investors for the development of new manufacturing units, in turn increasing demand for pipettes and accessories during the forecast period. Click To Reading More On Pipettes and Accessories Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Jan 14 2019 Hits: 24 Rating: 0.00 Votes: 0) Rate It

• Most Reliable Service by Global Air Ambulance Service in Tatanagar - January 12, 2019 – Our Company Global Air Ambulance, As everyone knows that Global is well reputed Air Ambulance provider Company and is well-developed and established only for the well-fare of the patient. It works 24 hrs to provide full safety and security to the patients while they are taken for the translocation from one place to another. As its main aim is to give the best service so, Yesterday it announced that it is going to give Tatanagar people a well-furnished air ambulance in which all the newest equipment and facilities will be included like medications, ventilators, ECGs and monitoring units, CPR equipment, scoop stretchers, wheelchairs, hi-tech ventilator, and cardiac monitor. Global Air Ambulance is one of the well occupied and reliable service providers which has all types of life-saving equipment’s to secure patients life and provide a better life for them. This Air Ambulance Service provides all the cost-effective elements that are very important for the patients while they are in the ambulance in a serious situation and they need fast and immediate treatment. Global Air Ambulance in Tatanagar based on a quick transfer service any serious or needy patient is being transferred under the supervision of best paramedics. Global Air Ambulance from Tatanagar is providing the Hi-Tech and advanced service medical evacuation system and all basic and advanced life-saving equipment’s which is described above in Tatanagar people. This Air Ambulance Service keeps all advances and best equipment’s so now you can easily get all benefits from here with an affordable range and economic price range. Global Air Ambulance from Kochi transfer patient under the supervision of specialized doctors and healthcare experts and keeps all the medical equipment ready to give immediate service to serious patients. More@ https://www.globalairambulance.in/air-ambulance-services-in-kochi/ (Added: Sat Jan 12 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Clinical Gastro 2019 - 13th International Conference on Clinical Gastroenterology and Hepatology. Gastroenterology is the study of normal functioning, diagnosis and treatment of stomach and intestinal disorders. The digestive track that starts from the mouth and runs up to the anus, encompasses of various organs such as alimentary canal, oesophagus, colon, rectum, pancreas, gallbladder, bile ducts, liver, duodenum, small intestine and large intestine. There are various accessory organs that assist the tract by secreting enzymes to help break down food into its component nutrients. Pulsus brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders or rub elbows with pioneers across the globe. London is all set for an amazing event as PULSUS proudly presents the “13th International Conference on Clinical Gastroenterology and Hepatology” slated on June 19-20, 2019 at London, UK. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of Gastroenterology from around the world to participate in the upcoming Clinical Gastro 2019. The meeting for this year will revolve around the theme “Gastroenterology: Pre-eminent Advancement and Clinical Aspects”. (Added: Sat Jan 12 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• 2018- 2024 Bone Graft Market | Material | Application | Size - The Growing Demands On Bone Grafts Market Globally And Its Exceptional Growth In Grafting Market Changing aspects of bone grafts market The market for bone grafts is ever growing due to the facts- • Increased cases of bone and joint disorders • Development in the department of synthetic bone grafts • Demand for bone and dental grafts • Technological advancements are bolstering the global bone grafts market. Though, expensive surgery cost and ethical issues related to use of bone grafts from animals or other religious beliefs are creating hindrance in the global bone grafts market growth. Also, rejection from the bone graft is a major setback in the growth of bone grafts market. Request Sample Report : https://bit.ly/2SJQLEi Market summary: The market players for bone grafts is growing at a steady rate with companies focusing on mergers, product innovations, collaborations and partnerships. With increasing bone and joint disorders with growing older population is the main boost for the market growth. With larger market players funding the smaller businesses to increase their market share. Australian Therapeutic Goods Administration cleared RTI surgical for nanoss bioactive bone void filler in 2016. Regional analysis: North America holds the strongest the position in the global bone grafts market owing to raise healthcare expending, developing healthcare infrastructure, and increased geriatric population. Europe market is growing due to increased bone diseases and encouraging regulatory activities showing substantial rate. Developing countries such as India and China is making their way in the market for bone grafts with growing infrastructure for healthcare. In the Middle East and Africa region, with large patient pool, South Africa is considered as the largest market. Some of the global bone grafts market players include • Olympus Corporation (Olympus Biotech Corporation) (Japan) • Wright Meadical Group N.V. (BioMimetic Therapeutics) (U.K.) • Johnson & Johnson Services, Inc. (DePuy Synthes) (U.S.) • Stryker Corporation (U.S.) • Regeneration Technologies, Inc.(U.S) • NuVasive, Inc. (U.S.) • NovaBone Products (U.S) • Medtronic.(U.S.) • Zimmer, Inc. (U.S.) • LifeNet Health, Inc. (U.S.) Notable market development: Dentsply international, Inc. and Sirona Dental systems, Inc. merged together in 2016 to form Dentsply Sirona International. The global bone grafts market is divided into following categories- By material • Natural o Autografts o Allografts • Synthetic o Ceramic o Composite o Polymer o Bone Morphogenetic Proteins By application • Craniomaxillofacial • Dental • Foot and Ankle • Joint Reconstruction • Long Bone Spinal Fusion By end-users • Hospitals • Ambulatory Surgical Centers • Dental Clinics By geographical regions • North America • Latin America • Europe • Asia-Pacific • The Middle East & Africa For More Information : https://www.precisionbusinessinsights.com/market-reports/global-bone-grafts-market/ (Added: Fri Jan 11 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Next Gen Sequencing (NGS) Market | USD 17.15 Billion 2024 | CAGR Of 18.6% - A Research Report On Next Generation Sequencing Market Comprising Of Market’s Current And Future Trends The Next Gen Sequencing (NGS) Market Is Projected To Reach USD 17.15 Billion By 2024 From USD 5.13 Billion In 2017, At A CAGR Of 18.6% During The Forecast Period Changing aspects of Next generation sequencing market The global next generation sequencing market is growing due to following factors such as- • Increase in gene mapping activities • Affordable cost of sequencing and technological development in personalized medicine • Adding to this, rise in R & D activities by market players, drug discovery applications However, dearth for skilled professionals, storage and management of patient data and ethical and legal issues related to the practices will hamper the next generation sequencing market. Request Sample Report : https://bit.ly/2KXG7GN Regional analysis: North America is anticipated to hold the largest share due to increased R & D activities for proteomic and genomic sequence, rise in adoption of next generation sequence techniques is helping to grow the market. Moreover, countries such as U.S., U.K. and Germany which are offering courses related to molecular biology which is also help to grow the next generation sequence market. Asia-Pacific is growing at faster rate in the global next generation sequencing market due to factors such as rising awareness about medical opportunities, increasing government initiatives and rise in partnerships and agreements among market players. Market summary: Local and international market players are actively involved in research, development and marketing of next generation sequencing market. Growing acquisitions, partnerships, collaborations and mergers are adopted by research laboratories and academic institutes and innovative products by market players are fueling the market of next-generation sequencing market. In addition to this, scientists and drug developers are working towards development of personalized medicine in order to boost the next generation sequencing market. Notable market development: Together with Amgen, Illumina’s next-generation sequencing cancer companion diagnostic test kit was FDA approved in 2017. Some of the players in global next-generation sequencing market are • Agilent Technologies, Inc. (U.S.) • Illumina, Inc. (U.S.) • Pacific Biosciences (Danaher Corporation) (U.S.) • Thermo Fisher Scientific Inc. (U.S.) • Qiagen N. V. (Germany) • Beijing Genomics Institute (China) • PerkinElmer, Inc (U.S.) • F. Hoffmann La Roche AG (Switzerland) • Genomatix GmbH (Germany) • Oxford Nanopore Technologies (U.K.) • Eurofins Scientific (U.S.) The global next generation sequencing market is divided into following categories- By product and service type • Pre-sequencing products and services market o DNA fragmentation, size selection, A-tailing, and end repair o Library preparation and target enrichment o Quality control • Sequencing services market o Targeted sequencing/gene panels o RNA-Seq o De Novo sequencing o Exome sequencing o Chip-Seq o Whole-genome sequencing o Methyl-Seq o others • Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market o NGS data analysis software & workbenches o NGS data analysis services o NGS storage management and cloud computing solutions By technology • Ion semiconductor sequencing • Sequencing by the synthesis (SBS) • Nanopore sequencing • Single-molecule real-time (SMRT) sequencing By application • Drug discovery • Diagnostics • Agriculture and animal research • Biomarker discovery • Precision medicine • Other applications By end-users • Biotechnology and Pharmaceutical Companies • Research Centres • Hospitals & Clinics • Others By geographical regions • North America • Latin America • Europe • Asia-Pacific • The Middle East & Africa For More Information: https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/ (Added: Fri Jan 11 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Gene Editing Market | $7,305.5 Million Value by 2024 | CAGR of 14.7% - Gene Editing Market | $7,305.5 Million Value by 2024 | CAGR of 14.7% A Steady Growth In Global Gene Editing Market Due To Newer Launches And Demand By The Consumers Gene Editing Market 2017 to Boom $7,305.5 Million Value by 2024 at a CAGR of 14.7% Changing aspects of gene editing Market Factors which are leading the growth of gene editing market globally are- • Demand for personalized medicine • Increased cases of cancer and other genetic disorders • Increased companies investments in R &D • Growth of pharmaceutical and biotechnology industries • Increased funding with rapid advancements and various drug discovery applications. Nonetheless, global gene editing market is hampered by strict government rules and regulations for approval, ethical issues, lack of awareness about the process and unavailability of gene editing therapeutics in the market. Request Sample Report: https://bit.ly/2DzbCWj Market summary: Gene editing market is heavily dominated by pharmaceutical and biotechnology sectors due to its drug discovery and therapeutics applications. Innovative research and development is what companies looking forward too, in addition to usage of CRISPR and ZFN. Many key market players are adopting strategies such as partnerships, collaborations, mergers and acquisitions which are driving the growth of genome editing market. An agreement was signed between Harvard (U.S), Institute of MIT and Sigma-Aldrich Corporation (U.S) to use CRISPR in 2014. Regional analysis: Due to strong presence of pharmaceuticals and biotechnology companies, North America dominates the gene editing market in global market. Developing global regions such as Latin America and Asia-Pacific is growing at a substantial rate in the global genome editing market due to research and development in the regions with automation in laboratories and instrumentation which is leading to expansion of leading genome editing companies. Notable market development: European patent for Cellectis was granted the invention of genetically T-cells by adopting RNA-guided endonucleases (centromere and Promoter factor 1 (Cpf1) or CRISPR associated protein 9(Cas9)) in 2017. Some of the key players in global genome editing market- • Cellectis S.A. (France) • Applied Stemcell, Inc. (U.S.) • Genscript (U.S.) • Merck KGaA (Germany) • Horizon Discovery Group plc,(U.K.) • Origene Technologies, Inc. (U.S.) • System Biosciences, Inc. (U.S.) • Sangamo Therapeutics, Inc.(U.S.) • Thermo Fisher Scientific (U.S) • Transposagen Biopharmaceuticals, Inc.(U.S.) The global gene editing market is divided into following categories- By technology • Zinc Finger Nuclease (ZFN) • Clustered regularly interspaced short palindromic repeats (CRISPR) • Transcription activator-like effector nuclease (TALEN) • Others By application • Cell Line Editing • Targeted gene mutation • Animal Genome Editing • Plant Genome Editing By product type • Consumables • Instruments and Software By end-users • Pharmaceutical companies • Biotechnology Companies • Academics • Clinical Research Organizations By geographical regions • North America • Latin America • Europe • Asia-Pacific • The Middle East & Africa For More Information: https://www.precisionbusinessinsights.com/market-reports/global-gene-editing-market/ (Added: Fri Jan 11 2019 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• Clostridium Vaccine Market Global Pipeline Analysis and Trend - There is a critical need for development of prevention vaccine for this disease. Clostridium difficile, is a gram-positive bacterium, which produces an anaerobic toxin that is transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. Growing C. difficile infections at healthcare facilities and antibiotic resistance to treatment drugs are propelling demand for development of prophylactic options to reduce the risk of infection in vulnerable patients. A 2013 bulletin published from the Centers for Disease Control and Prevention (CDC) outlined Clostridium difficile as urgent antibiotic-resistance threats in the U.S. Clostridium Vaccine Market Drivers Rising incidence and high prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period. Incidence of clostridium difficile infection has been witnessing an increase since the recent past, due to its infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), in 2015 around half a million people in the U.S. suffer from clostridium difficile infection in a year. Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016, reported significant incidence of clostridium difficile infection in China. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2359 Currently, there is no alternative therapies apart from antibiotics available for the treatment of clostridium difficile infection and only option available is surgery (in severe cases), fecal microbiota transplant, and probiotics in case of recurrent clostridium difficile infection. Moreover, key pharmaceutical players are engaged in conducting clinical trials for development of clostridium vaccine that can offer preventive measure in the clostridium difficile infection in near future. For instance, in January 2017; Pfizer announced phase II study of investigational clostridium difficile vaccine candidate: PF-06425090; for the prevention of C. difficile infection. This randomized phase II study was conducted to examine the safety, tolerability, and immunogenicity of the vaccine in healthy adults 65 to 85 years of age. Pfizer initiated a phase III study in March 2017, with around 16,000 participants. In July 2016, Valneva SE announced the successful completion of its phase II clinical study for its prophylactic vaccine candidate VLA84 targeting on primary prevention of C. difficile infection (CDI). Clostridium Vaccine Market Regional Analysis North America is expected to hold a dominant position in the global clostridium vaccine market and it is expected to account for largest market share over the forecast period, owing to increased prevalence of Clostridium difficile in the U.S. and growing awareness regarding the adoption of preventive measurement in Clostridium difficile infection in this region. For instance, according to CDC, in 2011; healthcare-associated infections (HAIs) caused by C. difficile was estimated to cause around half a million infections in the U.S. and 29,000 died within 30 days of the initial diagnosis. Clostridium Vaccine Market Restraint Increased risk associated with the failure of vaccine candidate during the clinical trial studies and high cost associated with late stage testing is expected to slow down commercialization of clostridium vaccine and restrain the clostridium vaccine market growth over the forecast period. For instance, in December 2017, Sanofi terminated its phase III C. difficile clinical trial studies, due to the results of an interim trial analysis, which stated low probability of success with its C. difficile candidate. Moreover, discontinuation of Sanofi’s C. difficile vaccine program is expected to offer great future opportunity for Pfizer and Valneva to offer its vaccine to patients after getting the satisfactory regulatory approval in the future. Click To Reading More On Clostridium Vaccine Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Fri Jan 11 2019 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• Veterinary Antiseptics Market: Presence of Production and Companion Animals to Drive the Growth - The rising demand for meat across countries of Asia Pacific, Latin America, and Rest of the World has led to an increased demand for veterinary antiseptics. The growing number of fitness-conscious people shifting their preference towards a protein-rich diet have spurred a high demand for animal healthcare. Read Report Overview: https://www.transparencymarketresearch.com/veterinary-antiseptics-market.html Furthermore, the rising disposable income levels that are allowing consumers to spend on various types of meat are also contributing to the revenues of the veterinary antiseptics market in Asia Pacific, Latin America, and Rest of the World in many direct and indirect ways. Antiseptics are used to heal wounds, prevent infections, sepsis, or putrefaction. They are also used to prepare the skin surface before injecting the animal. According to the research report published by Transparency Market Research, the opportunity in the Asia Pacific, Latin America, and Rest of the World veterinary antiseptics market will be worth US$401.6 mn by 2023 from US$243.0 mn in 2014. During the forecast period of 2015 and 2023, the market will surge at a CAGR of 5.6%, observes the lead analyst of the research report. The steady CAGR and positively rising revenues of this market will be attributable to the emerging trend of pet adoption in several developing countries. Pet owners are gradually gaining awareness about safeguarding their pets from infections and diseases, which has reflected on the increased uptake of veterinary antiseptics in the past few years. Asia Pacific holds the leading share in the veterinary antiseptics market in Asia Pacific, Latin America, and Rest of the World due to a strong presence of production and companion animals. The exponentially rising demand for good quality of animal-based products is expected to bolster this market in the near future. Furthermore, the growing demand for antiseptics for looking after domesticated animals is also adding to the revenues of the veterinary antiseptics market in Asia Pacific. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6448 According to the research report, the veterinary antiseptics market in Asia Pacific with be worth US$401.6 mn by 2023 as the market expands at a steady CAGR of 5.6% between 2015 and 2022. The increasing disposable incomes in China and India are encouraging consumers to adopt pets, which is expected have a positive impact on the overall market in the coming years. On the basis of product, the veterinary antiseptics market in Asia Pacific, Latin America, and Rest of the World is segmented into iodine and iodophors, chlorhexidine, alcohol, hydrogen peroxide, and others. Out of these, the iodine and iodophors segment is expected to grow at the fastest CAGR of 6.3% between 2015 and 2023. During this period, revenue from iodine and iodophors will rise to US$149.4 mn. The popular usage of iodine and iodophors is attributable to its mildness. Thus, it is extensively used for treating both small and large animals. For instance, the most commonly used form of iodophors is povidone-iodine as a solution or a scrub under the popular name of Betadine. During the same period, the chlorhexidine segment is expected to rise at a CAGR of 5.5% between 2015 and 2023. This antiseptic is largely used for cats, sheep, horses, cows, poultry animals, and dogs for treating their cuts, insect stings, and abrasions. Chlorhexidine is known for improving precipitation of salivary minerals, which leads to calculus in companion animals. Some of the key players in the market are Continental Manufacturing Chemist, Inc., Indian Immunologicals Ltd., M.B.D. Marketing (S) Pte Ltd., Bayer AG, Merck Animal Health, Merial, and Zoetis, Inc. Acquiring a talent pool by absorbing microbiologists and researchers through collaborations with academies will prove pivotal to the future of the companies. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6448 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 7 Rating: 0.00 Votes: 0) Rate It

• Cell Culture Protein Surface Coatings Market: Sales of Self-coating and Pre-coating to Drive Demand - Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering. Growing scope of cell culture and its applications has led to increased use of protein coated surfaces, as these provide better adhesion and proper nutrition for growth of the cells during cell culture. Read Report Overview: https://www.transparencymarketresearch.com/cell-culture-protein-surface-coatings-market.html Rising investment by government and market players in stem cell research and development activities is one of the major factors driving the cell culture protein surface coatings market. Becton, Dickinson and Company grants a total of USD 100,000 worth reagents every year to 10 scientists pursuing research activities in stem cells. Similarly, the European Union funded four stem cell research projects in its Seventh Framework Program for Research and Technological Development (2007 - 2013). High funding is leading to extensive stem cell research, resulting in increased use of cell culture protein surface coating products. Moreover, diverse applications of stem cells such as development of bone grafts and artificial tissue would fuel the demand for cell culture protein surface coatings during the forecast period. In addition, increasing cell culture applications in toxicology studies and cell-based assays would boost the demand for protein surface coating products. Currently, 2D cell culture is the most preferred technique by researchers worldwide due to lack of compelling data to switch to 3D cell culture. Based on the types of coating, the self-coating segment held the majority share of the total market in 2013 in comparison to pre-coating segment. The pre-coating segment is sub-segmented on the basis of different labware such as slides, micro-well/multi-well plates, flasks, petri dishes and cover slips. In terms of revenue, the micro-well/multi-well plates segment held the largest share of the total pre-coating market in 2013. The cell culture protein surface coatings market is also differentiated on the basis of protein sources, which include plant, animal, human and synthetic. The synthetic protein source segment is expected to grow at a faster rate in the global cell culture protein surface coatings market during the forecast period. Growth of the synthetic protein source segment is attributed to the rising demand for animal-free coating surfaces in North America and Europe and better attachment profile of poly-L-lysine and poly-L-ornithine. Geographically, North America and Europe dominated the cell culture protein surface coatings market in 2013 due to large-scale stem cell research activities and rapid adoption of advanced tools for cell culture. However, Asia Pacific is expected to grow at the highest CAGR due to the presence of untapped opportunities, increasing drug discovery activities, impressive development of healthcare and biotechnology infrastructure and growing trend among the market players to expand business in the region. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2993 The global cell culture protein surface coatings market is characterized by the presence of few big key players such as Corning Incorporated, Greiner Bio-One International AG, Merck Millipore, Sigma-Aldrich Corporation and Thermo Fisher Scientific, Inc. Corning’s acquisition of Becton Dickinson & Company has helped it to gain a dominant share in the global cell culture protein surface coatings market. Competition among these market players is high, which induces them to develop new and better protein surface coatings for cell culture and associated applications. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Nanomedicine Market: Growing Incidence of Chronic and Acute Diseases to Bolster the Market Demand - The rising applications of nanomedicine through breakthrough advancements in nanotechnology is perhaps the leading factor driving the global nanomedicine market. There has been a surge in research activities, by governments as well as private institutions, in the field of nanotechnology and in the experimental use of this technology to treat a variety of chronic conditions. This, coupled with high unmet medical needs, massive geriatric population, and growing incidence of chronic and acute diseases, is likely to give the market a significant boost. Read Report Overview: https://www.transparencymarketresearch.com/nanomedicine-market.html Registering a double-digit CAGR during the course of the forecast period, the global nanomedicine market is slated to amount to a value of US$177 bn by 2019. The major application segments of nanomedicine include cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. Amounting to a value of US$65.5 bn by 2019, oncology stands to dominate the global nanomedicine market throughout the forecast period. Compared to conventional drug therapies, nanomedicine has proven to present a number of benefits when it comes to the treatment of tumors. Nanomedicine has enabled targeted drug delivery through enhanced permeation and retention (EPR), giving this treatment the advantage of specificity compared to conventional non-targeted drug therapies. As a result, there has been increased focus on research in the use of nanomedicine for the treatment of cancer. In recent years, however, the focus on nanomedicine has moved toward its application in the neurology and cardiovascular segments. This can be attributed primarily to the rising availability of patient information and technological advancements. The cardiovascular segment is predicted to exhibit a CAGR of almost 16.0% during the forecast period. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1753 Accounting for an estimated share of over 35.0% in 2019, North America is slated to continue leading the global nanomedicine market throughout the forecast period. One of the most prominent factors that continues to drive this market is the increased presence of patented nanomedical products across the region. The presence of advanced and state-of-the-art healthcare infrastructure has greatly supported the development of nanomedical products such as nanorobots, DNA probes, monoclonal antibody-based immunoassays, nanosensors, and nanoparticle-based imaging agents. A favorable regulatory environment is also a major factor boosting the nanomedicine market in North America. Conducive legal and regulatory environment allows for the development as well as early acceptance of nanotechnology-based medical products. In addition to this, the rising incidence of cardiovascular and neurological diseases, cancer, kidney disorders, and other chronic conditions has spurred the need demand for personalized medicine, thereby supporting the nanomedicine market in North America. Although nanomedical products are still in their early stages of evolution and development in the emerging economies of Asia Pacific, the region is poised to expand at a rather strong pace over the course of the forecast period. Powered by countries such as India, China, and Indonesia, the APAC nanomedicine market is likely to be driven by increasing investments in R&D for the development and introduction of new drugs and therapies. A strong pipeline focused on various therapeutic areas is also anticipated to the growth of the nanomedicine Asia Pacific market. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1753 Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., GE Healthcare, UCB SA, Nanosphere Inc., CombiMatrix Corp, and Abbott Laboratories are some of the prominent players in the global nanomedicine market. It has been observed that competition in this market is largely on the basis of particular segments and there are only a handful of participants that cater to the complete manufacturing process. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Horseradish Peroxidase Market Statistical Analysis, Size, Share, and Forecast to 2026 - Horseradish peroxidase (HRP) is a metalloenzyme found in the roots of horseradish. It is used as an indicator enzyme in immunoassays and other biochemical research. Horseradish peroxidase catalyzes the conversion of chemiluminescent substrates for the detection of proteins, carbohydrates, and nucleic acids in chemical assays. Conjugates of horseradish peroxidase are commonly used in indirect assays, wherein the enzyme binds to an antibody which has been bound to a target molecule. The presence of horseradish peroxidase is made visible with the help of a substrate which is oxidized by HRP using oxidizing agent (hydrogen peroxide), after which HRP yields a characteristic color detectable by various spectrophotometers. Read Report Overview: https://www.transparencymarketresearch.com/horseradish-peroxidase-market.html Significant amplification of HRP conjugates, cost-effectiveness of HRP kits, and increase in R&D in the biochemistry sector are projected to be the key drivers of the global horseradish peroxidase market during the forecast period. However, rise in preference for alkaline phosphatase enzymes over horseradish peroxidase owing to stable and long-lasting signals generated by the latter is expected to restrain the global horseradish peroxidase market during the forecast period. The global horseradish peroxidase market can be segmented based on substrate type, application, and end-user. In terms of substrate type, the market can be categorized into tetramethylbenzidine (TMB), o-phenylenediamine dihydrochloride (OPD), 2, 2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 3,3'-diaminobenzidine (DAB), and others. The TMB segment accounted for the largest share of the market in terms of revenue in 2017, owing to significant compatibility with the detection imaging equipment. The segment is expected to continue to dominate the market during the forecast period, as TMB substrate oxidizes more quickly than others, resulting in faster color development. Based on application, the global horseradish peroxidase market can be divided into enzyme-linked immunosorbent assay (ELISA), Western blot test, Southern blot test, flow cytometry, and others. The ELISA segment captured the largest market share in terms of revenue in 2017, and the trend is likely to continue during the forecast period. Technological advancements in biomarkers and specific sensitivity of ELISA test are the key drivers of the segment. However, the Western blot test segment is expected to expand at the highest CAGR from 2018 to 2026 due to rise in R&D on highly sensitive biochemical tests involving less number of analytes. In terms of end-user, the global horseradish peroxidase market can be classified into academic institutes, research laboratories, diagnostic laboratories, biotechnological companies, and others. The research laboratories segment is projected to expand at the fastest CAGR during the forecast period, driven by significant investment by key companies to promote research on chronic disease treatment. The biotechnological companies segment accounted for a high market share in terms of revenue in 2017. Emergence of local and regional research-oriented biotechnological companies across the globe, and funding by government for R&D of novel biochemical solutions are projected to fuel the growth of the biotechnological companies segment during the forecast period. Geographically, the global horseradish peroxidase market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2017, attributed to strategic presence of key biotechnological companies in the U.S. and Canada, and government participation in promoting research on chronic diseases such as AIDS and cancer. Increase in demand for cost-effective biomarkers and indirect assays in Europe are anticipated to augment the global horseradish peroxidase market in the region from 2018 to 2026. However, the market in Asia Pacific is projected to expand at the highest CAGR during the forecast period, driven by rise in research grants and funding leverage to research laboratories in India and China. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45045 Prominent players operating in the global horseradish peroxidase market include Thermo Fisher Scientific, Inc., GenScript, RayBiotech, Inc., Promega Corporation, Takara Bio Company, Merck KGaA, Bio-Rad Laboratories, Inc., and Jackson ImmunoResearch, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 7 Rating: 0.00 Votes: 0) Rate It

• International Conference on Lifestyle Diseases and Management - Meetings International (Meetings Int.) invites you to attend the International Conference on Lifestyle Diseases and Management which is to be held on March 27-28, 2019 at Paris, France. This conference on Lifestyle Diseases and Management gives a chance to scientists, medical practitioners, research scholars and students to interact and share their knowledge and experience in different lifestyle diseases. It also provides a global opportunity to the people from both academia and industry to interact for a noble cause of bringing about a change in the society by exchanging their ideas and putting forth the causes and solutions to the effects of lifestyle diseases on a wide number of people worldwide. This conference aims at discussing the role of lifestyle in causing different chronic diseases which can be otherwise prevented by taking adequate measures. Lifestyle Diseases 2019 anticipates participants around the globe with thought provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. Students are warmly welcomed to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Lifestyle Diseases and Management. See more at: https://www.meetingsint.com/conferences/lifestylediseases Conference Highlights • Lifestyle Diseases • Hypertension and Lifestyle • Way to a Healthy Heart • Lifestyle and Being Obese • Insulin Junkie? • Lifestyle and Bones • Hormonal Play • Brain Drain • Are you Breathing Fresh? • Occupational Diseases • Depressed? Let us Talk! • Lifestyle and Cancer • The Healing Power of Yoga and Meditation • Diet for a Happy Life (Added: Fri Jan 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Calcium Phosphate Market Trends and Forecast to 2026 - Calcium phosphate is an important inorganic substance and is used in diverse industries, such as pharmaceuticals, nutraceuticals, food, etc. Calcium phosphate is a common pharmaceutical excipient, largely used as a filler and binder in solid and oral dosage forms. There are several types of calcium phosphates available in the pharmaceutical market, including fine materials as well as coarse DC grades for granulation processes. Important DC grades of calcium phosphate include dibasic calcium phosphate anhydrous, dibasic calcium phosphate dehydrate, and tribasic calcium phosphate. Due to high content of calcium and phosphorus are often used in dietary supplements. Several properties of calcium phosphate, such as compactness and excellent flow, mark them perfect candidates for direct compression processes. Read Report Overview: https://www.transparencymarketresearch.com/calcium-phosphate-market.html Factors such as wide acceptance of calcium phosphate, low product pricing, rising demand for healthy and nutritional food products, rise in orthopedic disorders, increasing use for calcium phosphate as diluents in drug formulations, and growing per capita and health care expenditure are likely to fuel the global calcium phosphate market. According to the Center for Disease Control and Prevention, an estimated 54.4 million adults in the U.S. were affected by arthritis in 2013-2015. Other factors such as government initiative in conducting awareness programs, growing geriatric population, and rising application of calcium phosphate in the pharmaceutical industry, including dental, orthopedic, tissue regeneration, etc. are expected to further drive the global calcium phosphate market. Governments, private organizations, and associations worldwide are taking measures to create awareness about oral health. For instance, the Centers for Disease Control and Prevention (CDC) partnered with the American Dental Association and the American Academy of Periodontology to improve and sustain surveillance of periodontal diseases in among the adult population in the U.S. On the other hand, the drug insoluble characteristics may hinder the market growth. For Instance calcium phosphate is insoluble in aqueous media at neutral or alkaline PH, which can impact on drug efficacy. The global calcium phosphate market can be segmented based on product type, end-user, and geography. In terms of product type, the calcium phosphate market can be classified into mono calcium phosphate, di calcium phosphate, and tri calcium phosphate. Based on end-user, the calcium phosphate market can be divided into pharmaceutical industry, nutraceutical industry, food industry, and others. In terms of geography, the global calcium phosphate market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global calcium phosphate market. Factors such as large geriatric population resulting in rising demand for bone and joint health supplements, increased research & development activities, and high consumption of nutritional products are likely to drive the calcium phosphate market in the region during the forecast period. According to the Centers for Disease Control and Prevention, an estimated 78.4 million adults are likely to be affected by arthritis by 2040. Europe is the second leading market for calcium phosphate. Factors such as increasing government focus on public health and rising investment in the pharmaceutical sector are the key drivers of the calcium phosphate market in the region. The calcium phosphate market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to rise in health care awareness among people, increase in health care expenditure, upsurge in demand for bone and joint supplements, prevalence of bone diseases, and growth of geriatric population, especially in Japan. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, Japan, the aged population (65 years and over) was 34.59 million in the country, constituting 27.3% of its total population in 2016. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44958 Major players operating in the calcium phosphate market include Advance Inorganics, Nitta Gelatin India Limited, The Mosaic Company, Merck KGaA, Chemische Fabrik Budenheim KG, Gadot Biochemical Industries LTD., and Innophos Holdings, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Halal Nutraceuticals & Vaccines Industry Outlook - A majority of global consumers for halal products are concentrated in APEJ and the Middle East & Africa (MEA) regions, with some of the prominent Halal Certifying Agencies located in countries such as Malaysia, Indonesia, UAE and Saudi Arabia. Acceptance of halal nutraceuticals & vaccines is expected to remain higher in APEJ and MEA regions, pertaining to the prevalent Muslim populations in their constituent countries. The global demand for halal nutraceuticals & vaccines will continue to be associated with acceptance of halal methods over other production methods. Regions such as North America, Latin America, Eastern Europe and Western Europe are less likely to become lucrative markets for halal nutraceuticals & vaccines, considering the consumer preferences for alternative vaccines and nutraceuticals in these regions. In 2015, revenues amassed from sales of halal nutraceuticals & vaccines in APEJ as well as MEA region surpassed over US$ 30 billion. According to research report compiled by Future Market Insights, the global halal nutraceuticals & vaccines market, which is currently valued at US$ 39,265 million, is projected to expand at a 7.7% CAGR and reach US$ 82,207 million over the forecast period, 2016-2026. More than 80% of global halal nutraceuticals & vaccines revenues will be accounted by the MEA and APEJ region collectively. Over the next decade, expanding the potential of global market beyond Muslim consumers will compel companies to urge multiple drug regulatory bodies and halal certifying agencies in the world for devising methods to produce halal nutraceuticals & vaccines for vegetarian consumers. Government initiatives for promotion of halal medications will also benefit the global halal nutraceuticals & vaccines market to a considerable extent. Future Market Insights’ report, titled “Halal Nutraceuticals & Vaccines Market: Global Industry Analysis & Opportunity Assessment, 2016-2026,” also delivers key research findings that indicate factors which are likely to inhibit the growth of global halal nutraceuticals & vaccines market. While lack of universal acceptance to halal products restrains an overall growth in the global demand for halal nutraceuticals & vaccines, limited sources for obtaining halal complaint ingredients is also expected to a major growth deterrent. High production costs for halal compliance and increasing presence of halal ingredients substitutes are also projected curb the production of halal nutraceuticals & vaccines by global leaders in pharmaceuticals industry. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2703 Leading Manufacturers of Halal Nutraceuticals & Vaccines Production of nutraceuticals and vaccines in compliance with halal methods becomes an intricate task for manufacturers, compelling them to induce more technological advancements in their production techniques. Companies manufacturing halal nutraceuticals & vaccines are obligated to work in accordance to the production regulations set by halal certifying agencies such as European Institute of Halal Certification (Germany), Global Halal Certification (UK), Halal Industry Development Corporation (Malaysia), and Saudi Food & Drug Authority (Saudi Arabia), among others. Such an interdependency might restrict manufacturers from producing halal nutraceuticals & vaccines at reduced costs, or even coerce the halal certifying agencies for approving certain techniques mounted by multiple dominant market players. Abbot Laboratories and Herbalife International of America, Inc. are two leading companies participating in the growth of global halal nutraceuticals & vaccines market. While Abbott Labs are expected to focus on producing halal nutraceuticals & vaccines for infants, women and specific therapeutic nutrition, Herbalife is directing its business measures more towards consumer awareness through promotional campaigns. Multinational F&B company like Nestlé S.A. and home care products conglomerate Amway are also increasing their presence in the global halal nutraceuticals & vaccines market. Chemical Company of Malaysia Berhad, PT Kalbe Farma Tbk, NoorVitamins, AJ Biologics Sdn Bhd., Agropur, Inc., and Kotra Pharma (M) Sdn Bhd, are also recognized as the leading companies in the global halal nutraceuticals & vaccines market. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-2703 Key Research Excerpts on Global Halal Nutraceuticals & Vaccines Market: Several global regulatory bodies such as the FDA are yet to approve commercialization of halal-certified vaccines, which is why vaccine products are less likely to enter the global market before 2018. Hospital pharmacies and retail pharmacies will remain the dominant distribution channels for halal nutraceuticals & vaccines through 2026, accounting for over US$ 50 billion in revenues towards the close of the forecast period. By 2026, global revenues generated from sales of halal nutraceuticals & vaccines for disease prevention applications will expand at the fastest CAGR – 9.2%. (Added: Fri Jan 11 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Sphincterotomes Market Outlook to 2026 Reported in Latest Research - A sphincterotome is an endoscopic surgery instrument which is employed to incise the sphincter. The device consists of an electrosurgical cutting wire which is partially covered by a Teflon catheter. The wire extends out of the catheter, through which the sphincter is incised. The procedure is commonly known as sphincterotomy. It is a complex procedure performed endoscopically. The procedure involves cannulation of the sphincter, followed by an electrocautery process to incise the sphincter. Depending on location of the sphincter, sphincterotomy procedures are of different types: lateral internal sphincterotomy, pre-cut sphincterotomy, and standard biliary sphincterotomy. These devices are available in various lengths and shapes. Biliary sphincterotomy is usually performed during endoscopic retrograde cholangiopancreatography (ERCP). The difference between a standard catheter and a sphincterotome lies in the electrosurgical cutting wire present in the sphincterotome. Read Report Overview: https://www.transparencymarketresearch.com/sphincterotomes-market.html Increasing incidence of anal fissure and reducing social stigma associated with its treatment in developing countries are factors leading to increase in the number of patients undergoing sphincterotomy procedures in these countries. According to the Centers for Disease Control and Prevention (CDC), an estimated 235,000 new cases of anal fissures are reported in the U.S. alone every year. This leads to around 150,000 patients undergoing standard biliary sphincterotomy in the country every year. Rising awareness about surgical treatment of anal fissures and increasing number of new and advanced sphincterotomes being offered in the global market are some of the major factors anticipated to drive the demand for new products in the next few years. This, in turn, is projected to drive the global sphincterotomes market from 2018 to 2026. However, lack of uniformity in the reimbursement for sphincterotomy procedures and sphincterotomes, especially in developing countries, is limiting the number of patients opting for surgical treatment of anal fissures. This is anticipated to restrain the global sphincterotomes market from 2018 to 2026. The global sphincterotomes market has been segmented based on product, feature, application, end-user, and region. Based on product, the global market has been segmented into pull-type sphincterotomes, push-type sphincterotomes, needle-type sphincterotomes, shark’s fin-type sphincterotomes, and others. Among these, the pull-type sphincterotomes segment accounted for the largest market share in 2017, owing to higher preference for this type of sphincterotomes by health care providers. Based on feature, the global sphincterotomes market has been divided into partially covered sphincterotomes and uncovered sphincterotomes. The partially covered sphincterotomes segment is anticipated to register a comparatively high CAGR from 2018 to 2026. Introduction of new products under this segment and ease of operation led to rise in the demand for partially covered sphincterotomes across the world in 2017. In terms of application, the global sphincterotomes market has been classified into standard biliary sphincterotomy, pancreatic sphincterotomy, lateral internal sphincterotomy, pre-cut sphincterotomy, and others. The standard biliary sphincterotomy segment dominated the global sphincterotomes market in 2017. Based on end-user, the market has been segmented into hospitals, specialty clinics, ambulatory surgery centers, and others. Based on region, the global sphincterotomes market has been segregated into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global sphincterotomes market in 2017 and is expected to continue its dominance during the forecast period. Increasing number of patients undergoing surgical treatment for anal fissure and high per capita health care expenditure in the region are some of the factors leading to the major share held by North America in the global market. The market in Asia Pacific is anticipated to register a comparatively high CAGR from 2018 to 2026, owing to rising awareness about surgical treatment of anal fissure and reducing social stigma associated with the treatment in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45117 Key players operating in the Sphincterotomes market are TeleMed Systems, Inc., Boston Scientific Corporation, OLYMPUS CORPORATION, Cook, ENDO-FLEX GmbH, CONMED Corporation, and MEDI-GLOBE CORPORATION. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Viral Vaccines Market Explores New Growth Opportunities by Leading Manufacturers - Vaccines are biological preparations, generally produced from living organisms that enhance immunity against a particular disease. Vaccines that prevent occurrence of a disease are called prophylactic vaccines and in some cases, treat diseases are called therapeutic vaccines. A vaccine is usually made from a weakened or killed form of the disease causing microorganism. The four primary types of vaccines are live attenuated vaccines, inactivated vaccines, conjugate vaccines, and toxoid vaccines. Viral vaccines contain killed or attenuated virus or their product that can activate the immune system to produce antibodies against them. The five types of viral vaccines are live whole viral vaccine, killed whole viral vaccine, subunit vaccine (purified or recombinant viral antigen), anti-idiotype antibodies, and DNA vaccine. Live viral vaccines are prepared by reducing virulence of pathogen, but keeping it alive. Killed viral vaccine consist of virus particle grown on culture and then killed by using heat or formaldehyde. Subunit vaccines (purified or recombinant viral antigen) are created by exposing viral particle in bacteria, yeast, or mammalian cell (an alternative application of recombinant DNA technology for production of hybrid virus vaccines). Anti-idiotype antibodies have the ability to mimic foreign antigen approach that leads to their development as vaccine to induce immunity against virus, bacteria, and protozoa in experimental animals. DNA vaccination involves direct introduction of genetically engineered DNA so that cells directly produce an antigen. Read Report Overview: https://www.transparencymarketresearch.com/viral-vaccines-market.html Rise in prevalence of several infectious and non-infectious disease, and technological advancements are projected to drive the global viral vaccines market during the forecast period. Additionally, large number of vaccination programs, government and non-government initiatives, and increase in demand for combined vaccine boost the growth of the market. However, cost associated with storage and transportation of vaccines and limited reimbursement coverage are projected to restrain the global viral vaccines market during the forecast period. Moreover, stringent government regulation for the approval of biological products is likely to hamper the growth of the market in the next few years. The global viral vaccines market can be segmented based on type of vaccine, indication type, route of administration, distribution channels, and region. In terms of type of vaccine, the global market can be bifurcated into preventive and therapeutic. Based on indication, the global viral vaccines market can be classified into influenza, hepatitis, chickenpox, smallpox, human papillomavirus infection, measles, mumps, rabies, rubella, polio or poliomyelitis, swine flu, yellow fever, and others. In terms of route of administration, the global market can be divided into oral and injectable. Based on distribution channel, the global viral vaccines market can be classified into online pharmacies, hospital pharmacies, and research institutes. In terms of region, the global viral vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to account for the largest share of the global market from 2018 to 2026, due to increase in initiatives by the United States Department of Health and Human Services (HHS). This is one of the key factors that encourages immunization programs in the U.S. Europe is expected to be the second largest market for viral vaccines during the forecast period, due to rise in prevalence of infectious diseases, government initiatives, and focused product development. The viral vaccines market in Asia Pacific is expected to expand rapidly during the forecast period. Growth of the market in the region is attributed to increase in awareness about prevention of bacterial diseases, rapidly developing health care infrastructure, and surge in adoption of technology in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45168 Key players operating in the global viral vaccines market are Seqirus A CSL, GlaxoSmithKline plc, Merck & Co., Inc. MedImmune, LLC, Emergent Product Development Gaithersburg, Inc., Novartis, Inc., Protein Sciences Corporation, Sanofi-Aventis U.S. LLC, Sanofi Pasteur, Serum Institute of India Ltd. In 2015, the EU commission approved the merger of Nimenrix and Mencevax vaccines businesses belonging to GlaxoSmithKline. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Asthma Monitoring Devices Market Growth Strategies and Comprehensive Forecast to 2026 - Asthma is a common chronic disease among children which worsens with age. Asthma is a complex inflammatory disease projected to be caused by genetic mutation or other environmental factors. In asthma, the airway muscles become hypersensitive to various allergens, which triggers inflammation of the muscular wall of airway tract, thereby narrowing the airway passage. The inflammation eventually leads to thickening of smooth muscle of the airway tract, which results in restricted air flow affecting the breathing process. Asthma attack can be lethal if not addressed or treated on time. In order to treat asthma, patients are administered with various drugs though inhalers and nebulizers that include albuterol, steroids, beta agonists, etc. Health monitoring of asthma patients and tracking of treatment are critical in the management of asthma. Asthma monitoring is done at hospitals and clinics, and even at home care settings. Technological advancements, such as, improved biomarker sensors, connected health care, and compact designing, have introduced new wearable asthma monitors and many such devices are in the development phase. Read Report Overview: https://www.transparencymarketresearch.com/asthma-monitoring-devices-market.html According to a report published by the World Health Organization in 2017, 235 million people across the world were affected with asthma and, in 2015, the disease accounted for 383,000 deaths worldwide. The Centers for Disease Control & Prevention of the U.S. states that, in 2016, around 26 million Americans were affected with asthma. The incidence rate of asthma is rising among children due to increasing susceptibility to various airborne allergens and other associated risk factors. According to the United States Environmental Protection Agency (EPA), in 2015, prevalence of asthma among children was 8.4% in the U.S. As the number of asthma cases is rising, demand for precise monitoring is driving the industry to develop new diagnostic and monitoring devices, such as, wearable and connected devices. However, high price of these devices and relatively low patient compliance to use advanced monitoring devices are likely to hamper the expansion of the market. Moreover, limited access to these devices in developing and underdeveloped markets is an area of concern among health care providers and researchers. Asthma monitoring devices are non-invasive devices which use different parameters to monitor the patients’ health, treatment compliance, onset of asthma attack, etc. The global asthma monitoring devices market can be segmented based on technology, ergonomics, end-user, and geography. Based on technology, the global market can be divided into peak expiratory flow (PEF) measurement, forced expiratory volume (FEV1) measurement, acoustic measurement of breathing sounds & wheezing, exhaled nitrite measurement (FeNO), and others. PEF and FEV1, which are widely applied techniques in peak flow meters, are likely to get replaced by the advanced and patient-friendly FeNO and acoustic measurement based monitoring devices. Most of these devices are offered as compact wearable devices with mobile connectivity for data sharing. In terms of ergonomics, the global market can be classified into bench-top, wearable, and handheld devices. Based on end-user, the global asthma monitoring devices market can be categorized into hospitals & clinics, home care settings, and others. In terms of geography, the global asthma monitoring devices market can be categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is projected to account for a leading share of the global market during the forecast period, due to high adoption of technically advanced medical devices and awareness for personalized health care facilities in the region. Moreover, most of the key industry players are based in the U.S., which is estimated to augment the growth of the market. Europe is anticipated to account for a significant share of the global asthma monitoring devices market during the forecast period. Well-established health care infrastructure and increasing demand for preventive health care in the European countries are the key factors driving the expansion of the global asthma monitoring devices market in the region. Increasing awareness of asthma and rising private health care expenditure in emerging markets, such as China and India, is anticipated to boost the asthma monitoring devices market in Asia Pacific. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45108 Major players operating in the global asthma monitoring devices market are Respiri Limited, Spirosure Inc., Volansys Technologies Pvt. Ltd., Vitalograph, Health Care Originals, Inc., Microlife Corporation, OMRON Healthcare, and others. Besides these key players, many public hospitals and universities, such as, University of Rochester, Rutgers University, etc. are also developing new asthma monitoring devices. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Medical Imaging Phantoms Market: Rise in Adoption of Advanced Imaging Methods to Drive Market - Medical imaging phantoms are devices used as substitute of human tissue. These ensure that medical imaging systems provide reliable and quantitative information. Calibration carried out using phantoms is traceable and as per national and international standards. Advantages offered by medical imaging phantoms are improved medical imaging technique, speedy clinical trials of drugs, and consistent, accurate, and optimal results. These also play a crucial role in innovation and development of advanced diagnostic imaging techniques. These advantages are expected to propel the global medical imaging phantoms market during the forecast period. Read Report Overview: https://www.transparencymarketresearch.com/medical-imaging-phantoms-market.html The global medical imaging phantoms market was valued at US$ 131.2 Mn in 2017 and is projected to reach US$ 180.0 Mn by 2026 at a CAGR of 3.6% from 2018 to 2026. Improved medical imaging due to usage of medical phantoms, reduced exposure to radiation, increase in efficiency of medical devices, and rise in adoption of advanced imaging methods are likely to drive the global market during the forecast period. Cost concerns, human resource & time constraints, and highly complicated maintenance are anticipated to restrain the global market in the near future. However, emerging economies such as India, China, Brazil, Russia, Mexico, and South Africa offer immense opportunities in the medical imaging phantoms market. This is attributed to large number of underserved patients, rise in proportion of urban population, and favorable insurance policies. The global medical imaging phantoms market has been segmented based on device type, end-user, and region. In terms of device type, the global market has been classified into X-ray/fluoroscopy phantoms, ultrasound phantoms, CT phantoms, MRI phantoms, nuclear imaging phantoms, and others. Usage of diagnostic radiology is expanding to diagnosis of cancer, brain injury, other diseases, and medical implants. Medical imaging devices scan phantoms which serve as alternatives for living subjects or cadaver. Scanning the phantoms reduces the chances of a patient getting exposed to excessive radiation, as it induces cellular structure and DNA damage. It also helps reduce misdiagnosis of diseases, thereby increasing the overall diagnostic efficiency of medical imaging devices. Medical imaging phantoms have applications in increasing accuracy of medical imaging devices which indirectly helps medicine practitioners and experts to evaluate, interpret, analyze, and produce quality data needed for medical advice and treatment. These factors are likely to propel the market during the forecast period. In terms of end-user, the global medical imaging phantoms market has been classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and medical device companies. The medical device companies segment is expected to dominate the global market during the forecast period. Geographically, the global medical imaging phantoms market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. It is expected to continue this trend during the forecast due to high adoption of superior technologies across all end-user segments. Moreover, investments in cutting edge research, rising emphasis on remedies for diagnosis concerns, and concentration of some of the world’s major pharmaceutical and biotechnology organizations and academic institutes in the region are expected to propel the medical imaging phantoms market in this region. Asia Pacific and Middle East & Africa are expected to gain market share during the forecast period. Asia Pacific is expected to gain market share owing to rise in prevalence of chronic disorders and surge in awareness about medical imaging phantoms among the people. Rise in disposable income of people also contributes to the growth of the market in Asia Pacific. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=45042 Major players operating in the global medical imaging phantoms market are PTW Freiburg GmbH, Gold Standard Phantoms, Kyoto Kagaku Co. Ltd., Pure Imaging Phantoms, Dielectric Corporation, Modus Medical Devices, Inc., Carville Limited, Computerized Imaging Reference Systems, Inc. (CIRS, A Castleray), Biodex Medical Systems, Inc., and Leeds Test Objects Ltd. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Fri Jan 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Air Ambulance in Jaipur with Well-Experienced MD Doctors - January 11, 2019 - Global Air Ambulance, Yesterday it announced that it is going to provide an equipped ambulance with medical equipment vital to monitoring and treating injured, ill or accidental patients in Jaipur city which is well known as pink city. Jaipur is a very beautiful city and its the capital city of India state Rajasthan. Global Air Ambulance equipment for air ambulances includes medications, ventilators, ECGs and monitoring units, CPR equipment, scoop stretchers, and wheelchairs. Global Air Ambulance provides emergency transfer services from one city to another city by bed-to-bed service provider all over in India. It has a great team of MD Doctors and best team of paramedical technicians and also Medical Charted Aircraft with all advanced equipment’s. Global Air Ambulance in Jaipur is one of the best service providers all over the Jaipur city provides all advanced and basic life-saving equipment’s in an affordable range to secure patients life. It provides each and every ICU emergency requirements for serious patients. Global Air Ambulance Service in Jaipur confers you the fastest Air Ambulance services which consist of specialized doctors, medical team and advanced medical services you want. It is well established for critical and serious patient transfer through air ambulance with standard care and management. Global Air Ambulance from Jodhpur provides complete bed-side to bed-side transfer and has newest ICU medical equipment and always stands ready in a critical situation to provide all levels of care and treatment for Air Ambulance Medical Services as you never know when a patient will require the best level of care from Air Ambulance Services. Learn more: Global Air Ambulance Services with Quick and 24/7 Services More@ https://www.globalairambulance.in/air-ambulance-services-in-jodhpur/ (Added: Fri Jan 11 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• 11th Asia Pacific Global Summit on Healthcare - Healthcare Asia Pacific 2019 Inviting Healthcare Professionals and representatives from around the globe to go to "11th Asia Pacific Global Summit on Healthcare" During May 08-09, 2019 Tokyo, Japan. This consolidates incite keynote presentations, Oral talks, Poster presentations and Exhibitions.The Theme of the meeting is "Leading Innovation For Better Healthcare And Nursing Systems". The gathering invites speakers from social Healthcare Universities, clinical research associations, expository associations, Healthcare Societies and Healthcare ventures to share their investigation experiences on all parts of this rapidly developing field and thusly, giving a show off of the latest Healthcare Techniques. For more details kindly visit our link: https://healthcare.global-summit.com/ Special Sessions: Healthcare And Management, Public Health & Community Healthcare, Primary Healthcare, Cardiac Healthcare, Women’s Health, Gynecology & Obstetrics Disorders, Healthcare And Patient Safety, Healthcare: Sexual Health, Nursing Education, Infectious, Chronic Diseases & prevention, Obesity & Associated Health Disorders, Cancer and care, Occupational Healthcare, Digital & Dental healthcare, Healthcare and Innovations, Psychiatric and mental Healthcare, Pediatric Healthcare, Healthcare informatics & e-Health, Nutrition and Healthcare, Ambulatory Healthcare Services Target Audience Allied Health Professionals, Healthcare Professionals, Nurse practitioners, healthcare Administrators, Physicians, Healthcare Associations and societies, Healthcare Universities, Doctors, Professors, Associate Professors, Healthcare industries, Primary healthcare specialists, Family Medicine Specialists, Healthcare Researchers, Primary and Community care Specialists, Public Health Specialists, Internal Medicine Physicians, Healthcare Associations and Societies, Business Entrepreneurs, Training Institutes, Software developing companies, Manufacturing Medical Devices Companies, Data Management Companies Venue: Radisson Hotel Narita, Tokyo, Japan 650-35 Nanae, Tomisato, Chiba Prefecture 286-0221, Japan 1-650-889-4686 (Added: Fri Jan 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• NuAxon Bioscience Promotes Tena Edwards to Chief Operating Officer - Bloomington, IN: (January 10, 2019) Today, NuAxon Bioscience’s Board of Directors and Executives proudly announce Tena Edwards as the new Chief Operating Officer (COO). NuAxon manufactures and distributes botanical products around the world and is headquartered in Indiana, USA. Garish Soman, the Board Chairman of NuAxon and the CEO of NuAxon’s sister company Nisarga Biotech PVT Ltd, stated that “Tena’s promotion is long overdue, as she is a valuable member of the NuAxon team. Her current appointment as COO greatly strengthens our board”. Tena Edwards began as a finance manager with the company when it was founded in 2012. She became the Operations and Facilities Manager in 2013, and is vital to the company’s inner and outer workings. She was promoted to COO on January 1 of this year. NuAxon manufactures and produces organic herbal products, including supplements, powders and vapors. The company works closely with Nisarga Biotech PVT Ltd . All of NuAxon’s innovative herbal supplements are made exclusively from plants that are grown and harvested on their jointly owned certified organic farms located south of Mumbai, India. Nisarga Biotech is a company that manufactures a wide range of CO2 extracted essential oils and herbal concentrates that are used across the globe in the natural product and organic industry. Rebel Herbs and Intelligence Tree Botanicals are two lines of innovative organic herbal products that are under NuAxon.The company is certified organic, eco certified and certified by IMOswiss AG, under the "Fair for Life" program. The companies’ operations are sustainable. Not only do they grow their own organic produce, but they also gather and educate local farmers on organic and sustainable growing practices. The company funds local farmers’ certification and contracts them to grow and supply herbs and spices. The company looks to build a long term revenue engine for everyone in its chain of supply. The company has established that its workers are paid 20% more than the average wage for their positions. This has helped over 400 employees living in India provide a better life for their families. Furthermore, this method provides the crucial processes that the company has for full control of its product from soil to shelf, in addition to minimizing environmental impact. (Added: Thu Jan 10 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Osteonecrosis Treatment Market to Experience Significant Growth from 2018 to 2026 - Osteonecrosis, also known as aseptic necrosis, is a condition which occurs due to loss of blood flow to the bone. Bone is a living tissue which requires regular supply of blood. Any disruption to the supply of blood can cause the bone to die, and if the process is not stopped in time, it can lead to eventual collapse of the bone. Degenerative arthritis, particularly of the knees and hips and to a lesser extent of the hands, shoulders, and feet, may be caused due to bone collapse. Osteonecrosis is caused due to serious trauma injuries, excess consumption of alcohol, chronic use of corticosteroid, systemic lupus erythematous, decompression disease, blood disorders such as antiphospholipid antibody syndrome (APS), sickle cell anemia, and HIV infection, among others. Read Report Overview: https://www.transparencymarketresearch.com/osteonecrosis-treatment-market.html A prominent factor contributing to the growth of the osteonecrosis treatment market is the rise in consumption of alcohol observed across the globe. In the U.S alone, the number of people consuming alcohol has risen exponentially during the period 2002-03 to 2012-13, according to an independent study conducted by the National Institute on Alcohol Abuse and Alcoholism. The study also finds that the number of female alcohol consumers has more than doubled in the reported time period. Excessive alcohol consumption over a considerable period of time leads to abnormal lipid metabolism, which is a prominent risk factor for alcohol-induced osteonecrosis. Rise in hip injuries owing to surge in geriatric population is expected to drive the osteonecrosis treatment market during the forecast period. Hip injuries may lead to interruption of flow of blood to the bone, causing trauma-related avascular necrosis. Osteonecrosis may develop in 20% of the people with hip injuries. According to the United Nations’ World Population Ageing report, the number of people above the age of 60 years stood at 962 million in 2017, which is projected to reach 2.1 billion by 2050, globally. Rise in geriatric population is anticipated to increase the number of cases of hip injuries, which in turn, augments the patient population suffering from osteonecrosis. This is likely to drive the demand for medications and therapies used to manage these conditions. Additionally, ongoing measures undertaken by biotechnology companies aimed at developing novel treatment options for people suffering from osteonecrosis is also expected to drive the growth of the osteonecrosis treatment market. In September 2017, Bone Therapeutics, a biotechnology company engaged in developing cell therapy-based products for bone diseases and orthopedics and Asahi Kasei Corporation, a major chemicals company, entered into an exclusive royalty bearing license agreement for the development and commercialization of PREOB, an autologous bone cell therapy product developed by Bone Therapeutics, in Japan. Such strategic initiatives focused on launch of new and effective treatment options for managing this condition is likely to boost the osteonecrosis treatment market during the forecast period from 2018 to 2026. The global osteonecrosis treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the market can be classified into non-surgical treatment and surgical treatment. Based on end-user, the osteonecrosis treatment market can be divided into hospitals, ambulatory surgical centers, and orthopedic clinics. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52395 In terms of region, the global osteonecrosis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global osteonecrosis treatment market due to launch of new treatment options in the region. The osteonecrosis treatment market in Asia Pacific is projected to grow significantly during the forecast period owing to the increase in geriatric population in the region. Key players operating in the global osteonecrosis treatment market include Bone Therapeutics SA, Enzo Biochem Inc, Integra LifeSciences Corporation., and K-Stemcell Co Ltd. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 10 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Human Chorionic Gonadotropin Market Outlook Upto 2026 - The global Human Chorionic Gonadotropin (hCG) market has been growing at a phenomenal pace since the past few years due to rise in infertility in women. Changing lifestyles and poor dietary habits are expected to make a significant contribution to the soaring revenue of the hCG market. Gynecology is the fundamental branch of medicine concerned with medical issues among women. It incorporates conditions related to wellbeing of women and their screening and testing methodology. Female body is particularly prone to different types of cancer, such as, breast cancer, cervical cancer, and ovarian cancer. Other rising medical conditions comprise infertility, polycystic ovarian disorder, menopause, osteoporosis, depression and obesity. Human chorionic gonadotropin is a hormone produced by placenta in a pregnant women and is a type of gonadotropin hormone. Read Report Overview: https://www.transparencymarketresearch.com/human-chorionic-gonadotropin-market.html Rise in availability of treatment and services regarding infertility and increase in awareness about therapeutics for infertility issues are boosting the demand for human chorionic gonadotropin (hcG) hormone in developing countries. Increasing prevalence of hypogonadism-related disorders in males, especially in elderly men, is a primary driver of the human chorionic gonadotropin (hCG) market as recently hcG hormone is also used in treating males hypogonadism. Efforts of global health organizations and voluntary organizations for improving the sexual health of people in underdeveloped countries are also stoking the demand for hCG hormone. In addition, sedentary lifestyle and stress concerning personal and professional life have also led to fertility-related issues. Urban women tend to seek medical help for women-centric ailments that may impact the quality of life. Rise in elderly women population is another factor propelling the growth of human chorionic gonadotropin (hCG) market. However, FDA has issued certain warnings against the side-effects associated with using human chorionic gonadotropin as a treatment, which is anticipated to act as a restraint to the growth of the human chorionic gonadotropin (hcG) market in the near future. The global human chorionic gonadotropin (hCG) market can be segmented on the basis of technology, therapeutic area, end-user, and region. Based on technology, the market can be divided into natural source extraction and recombinant technology. In terms of therapeutic area, the market can be classified into male hypogonadism, infertility treatment in women, oligospermic treatment, and others. Among these, infertility treatment in women constitutes the dominant share of the global human chorionic gonadotropin market. On the basis of end-user, the market can be segmented into fertility clinics, research institutions, and others. Geographically, the global human chorionic gonadotropin (hCG) market can be distributed into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to remain the leading market for human chorionic gonadotropin due to focus on innovation in technology to introduce new, advanced techniques with more particular treatment; better spotlight on infertility treatment, and presence of significant global pharmaceutical and biotechnology associations in the regions. The human chorionic gonadotropin (hCH) market in Asia Pacific is projected to grow rapidly during the forecast period. Increase in patient population and rise in awareness regarding health care treatment facilities and services are fuelling the growth of the human chorionic gonadotropin (hCG) market. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52398 Major players operating in the global women health diagnostics market include Bristol Myers Squibb Company, Merck & Co., Inc., Cigna, Lee BioSolutions Inc., Scripps Laboratories, Ferring Pharmaceuticals Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Sanzyme, and LUPIN. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 10 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Hashimoto's Thyroiditis Diagnostics and Treatment Market Analysis and In-depth Research - Hashimoto's thyroiditis is an autoimmune disease. It also known as Hashimoto's disease. It is a medical condition, wherein the thyroid gland does not produce enough hormones needed by the body. The thyroid gland is located in the front of the neck. Hormones play a key role in the body and control the metabolic activity. Read Report Overview: https://www.transparencymarketresearch.com/hashimotos-thyroiditis-diagnostics-treatment-market.html Actual cause of Hashimoto's thyroiditis is unknown. However, scientists and professionals believe few factors play a key role including genes, hormones, excessive iodine, and radiation exposure. Researchers believe that certain drugs and high iodine level leads to Hashimoto's thyroiditis. Studies indicate that sex hormones could also be leading cause of the disease. Symptoms of the disease could take some time to appear. The first sign and symptom of Hashimoto's thyroiditis is enlarged thyroid, also known as goiter. Nails become brittle or break easily, slowed heart rate, hair loss or thinning, brittle hair, depression, inability to get warm, paleness or puffiness of the face, weight gain, difficulty getting pregnant, fatigue, constipation, depression, and irregular or heavy menstrual periods are others signs and symptoms of Hashimoto's thyroiditis. Thyroid-stimulating hormone test, anti-thyroid antibodies test, and free T4 test are the major tests for Hashimoto's thyroiditis. Heart problems, myxedema, and goiter and mental health issues are the major complications of Hashimoto's thyroiditis. Increase in incidence of thyroid gland disorders and rise in number of disease awareness programs in developing regions are the major factors driving the Hashimoto's thyroiditis diagnostics and treatment market. However, asymptomatic nature of thyroid disorders leading to large pool of undiagnosed patients is a key restraint of the market. The global Hashimoto's thyroiditis diagnostics and treatment market can be segmented based on diagnostic test & treatment, end-user, and region. In terms of diagnostic test & treatment, the market can be bifurcated into medications and diagnostic tests. Diagnostic tests can be divided into anti-thyroid antibodies tests, thyroid-stimulating hormone test, and free T4 test. Anti-thyroid antibodies test is also known as thyroid peroxidase antibody test or anti-thyroglobulin antibody test. Based on end-user, the global Hashimoto's thyroiditis diagnostics and treatment market can be classified into hospitals, clinics, and medical laboratories. In terms of revenue, the hospitals segment held a significant share of the market in 2017. In terms of region, the global Hashimoto's thyroiditis diagnostics and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the Hashimoto's thyroiditis diagnostics and treatment market in North America in terms of revenue. The market in Asia Pacific is projected to expand at a rapid pace due to increase in the number of patients suffering from Hashimoto's thyroiditis. Moreover, Asia Pacific is projected to be a highly attractive Hashimoto's thyroiditis diagnostics and treatment market in the near future. This is due to the presence of emerging economies such as India, China, and Japan; better health care infrastructure, economic growth, rise in the number of insurance payers, expanding and developing private health care sector, and increase in awareness among people. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52401 Key players in the global Hashimoto's thyroiditis diagnostics and treatment market include Bio-Rad Laboratories, Abbott Laboratories, Inc., SQI Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Pfizer, Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Sanofi, AbbVie, Inc. and Novartis AG. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 10 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Hip Reconstruction Devices Market is driven by the Technological Advancements in these devices - With ever-rising geriatric population, the market for hip reconstruction devices has gained an impetus across the world. The increasing incidence of hip injuries and fractures, osteoarthritis, and wearing down of joints over time in aged people has fueled the need to reconstruct their hip joints, which is reflecting significantly over the demand for hip reconstruction devices. The overall opportunity in the global market for hip reconstruction devices was worth US$5.68 bn in 2016. Going forward, the technological advancements in these devices are anticipated to continue propelling this market over the next few years, bringing in exceptional growth. Read Report Overview: https://www.transparencymarketresearch.com/hip-reconstruction-devices-market.html On a wider level, the global market for hip reconstruction devices is assessed on the basis of the product, indication, and the end user. Revision hip replacement device, primary cemented hip replacement device, partial hip replacement device, primary cementless hip replacement device, and hip resurfacing device are the key products available in this market. Among these, the demand for primary cemented hip replacement devices is relatively higher. Over the forthcoming years, this demand is likely to increase substantially, adding US$126.6 mn per annum in revenues over the period from 2017 to 2022. By indication, the worldwide market is bifurcated into rheumatoid arthritis, osteoarthritis, and trauma. Elderly people, suffering from osteoarthritis and rheumatoid arthritis, are the main consumers of hip reconstruction devices across the world. Hospitals, ambulatory surgical centers (ASCs), and orthopedic clinics have surfaced as the main On the regional basis, the worldwide hip reconstruction devices market is considered to have a reach across Asia Pacific excluding Japan (APEJ), the Middle East and Africa (MEA), North America, Europe, and Japan. With an expected US$2.11 bn in revenues by 2017, North America is the current market leader. The increasing preference for minimally invasive surgeries among patients and medical practitioners is projected to fuel the demand for hip reconstruction devices in this region over the next few years, ensuring its dominance. The presence of a large pool of the manufacturers of hip reconstruction devices is also projected to support the market in North America in the near future. Europe, with a CAGR of 5.90% between 2017 and 2022, is expected to retain its second position throughout the forecast period, thanks to the presence of advanced medical infrastructure and favorable reimbursement policies. Among other regional markets, Asia Pacific excluding Japan is anticipated to report a significant rise at a CAGR of 6.20% during the period of the forecast. The steady increase in the disposable income of consumers in developing Asian countries, such as India, China, and South Korea, enabling then to afford expensive treatments, is the key factor behind the growth of the Asia Pacific market for hip reconstruction devices. In addition to this, the thriving medical tourism industry in this region is projected to support this regional market over the next few years. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10307 The global market for hip reconstruction devices is highly competitive and fragmented on nature. United Orthopedic Corp., MicroPort Scientific Corp., Exactech Inc., Waldemar LINK GmbH & Co. KG, Corin, Zimmer Inc., Braun Melsungen AG, DePuy Synthes, Smith & Nephew, and Stryker Corp. are some of the key manufacturers of hip reconstruction devices across the world. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 10 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Medical Electrodes Market Value to Reach US$ 857 Mn by 2022 - The use of medical electrodes to transfer the current energy into the electric energy in the body, which helps in detecting a large number of diseases has supported the growth of the medical electrodes market in the last few years. The rising developments and advancements in this field is another major factor that is predicted to accelerate the growth of the overall market in the coming years. Read Report Overview: https://www.transparencymarketresearch.com/medical-electrodes-market.html According to the market research study by Transparency Market Research, in 2017, the global market for medical electrodes was worth US$641.3 mn and is projected to reach a value of US$857 mn by the end of 2022. The market is predicted to register a healthy 6.0% CAGR between 2017 and 2022. The increasing incidence of neurological and cardiovascular diseases is one of the major factors that is estimated to encourage the growth of the global medical electrodes market in the next few years. The rising investments by the key players for the research and development activities is projected to accelerate the growth of the overall market in the coming few years. In addition to this, the rising preference of consumers for ambulatory and home healthcare is estimated to generate promising growth opportunities for the market players in the next few years. On the flip side, the lack of knowledge among people regarding the availability of these technologies, especially in developing economies is likely to hamper the growth of the overall market in the next few years. Nonetheless, the rising trend of medical tourism is projected to enhance the growth of the overall market in the near future. Moreover, the increasing popularity of nanotechnology is expected to support the growth of the medical electrodes market in the next few years. Among the key regional segments, North America is projected to remain in the leading position in the next few years, accounting for a large share of the overall market. The presence of several leading players is one of the key factors estimated to encourage the growth of this region in the next few years. In addition to this, the rising research and development activities and the rising focus of the key players on the development of the new product are further projected to accelerate the growth of the medical electrodes market across North America in the next few years. Furthermore, Europe and Asia Pacific is predicted to witness a healthy growth in the next few years. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30887 The global market for medical electrodes is competitive in nature with a large number of players operating in it. The level of fragmentation is estimated to rise significantly in the next few years, thanks to the rising number of player projected to enter the market in the next few years. Some of the leading players in the medical electrodes market across the globe are Pacetronix Limited, Boston Scientific Corporation, Abbott Laboratories, Zoll Medical Corporation, Biotronik SE & Co. KG, Medtronic Plc., OSYPKA AG, Lepu Medical Technology, and Oscor Inc. The players are focusing on the research and development activities in order to maintain their dominance in the global market in the next few years. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Thu Jan 10 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Advanced and Hi-tech service by Global Air Ambulance in Jabalpur - January 10, 2019 - Global Air Ambulance, Yesterday it came with the good news that they are going to provide the well-furnished air ambulance and the best and newest medical equipment to the Jabalpur people at manageable cost. The price will be so reliable that even poor patients can easily afford it. This Air Ambulance will keep all the ICU, CCU, and Ventilators facilities so that in any emergency patients should be given quick treatment so that he can be comfortable at the moment. Global Air Ambulance in Jabalpur is always ready to take off the most serious and Critical patient from one City Hospital bed to another City Hospital bed this air Ambulance Service in one of the time saving and quick service provided by private Chartered aircraft and commercial and line equation service and other Jet Airline medical transfer facility. This Air Ambulance Service always takes care of the focus and suggested the guest best option and most economical expense transfer facility in connection with the serious. This error balance service profile best emergency transfer service from one City Hospital to another City Hospital under the supervision of MD doctor and paramedical technician this service is one of the covered with 365 days emergency Ambulance Service Provider which has all types of basic and advanced amenities available to the serious from one date to another bed under the king and a specific supervision of medical assistance and paramedics team. Global Air Ambulance from Jamshedpur teams is always ready to provide on-call assistance in order to safely transport a patient from one city to another city. Web@ https://www.globalairambulance.in/air-ambulance-services-in-jamshedpur/ (Added: Thu Jan 10 2019 Hits: 16 Rating: 0.00 Votes: 0) Rate It

• EverythingHealth - Have You Gained Weight Because of These Bad Habits? Here are the Solutions! Obstinate habits related to health take a significant toll on life. To survive a healthy life balanced diet and exercises should be on the top of your every day’s schedule. Here’s a list that explains the reasons & solutions of weight gain due to bad habits: Everything Health 1.Racing Through the Meal Have you ever noticed your eating speed? It may sound trivial, however, eating too fast poses the vulnerability of taking too many calories even before you realize that you’ve overeaten. According to a study published in the Journal of the American Dietetic Association, people who gallop food are more likely to become obese in comparison to the diners who eat slowly. Solution- Eat slowly and mindfully because only then you’ll be able to realize your brain’s signal of fullness. Take approx. Twenty minutes to finish one meal. Don’t swallow the food and try to chew the food until it's broken down into minute bites. 2. Busy Enough for Exercise Eating healthy is a mandate, but above all physical activities in the form of exercises, sports, or athletics are the lifeline. Stick to this thumb rule, burn extra calories every day through physical workout else someday or other you’ll face severe complications with your health. Solution- Hit the gym or start practicing yoga/ aerobics or any other form of physical workout. Dancing or playing sports can also pull you out of your lazy comfort zone. 3.Lack of Enough Sleep Do you know, if you suffer sleep loss too frequently, then you are likely to feel hungry even if you are full. This is because sleep loss affects the secretion of a hormone called cortisol. Cortisol is responsible for regulating appetite. Studies suggest that sleep loss augments fat storage in the body. Solution- Sleep for at least 8 hours a day. 4.Drinking Without Thinking Your cocktails, beer, alcohol, wine or soft drinks may go down quickly, but just to fill the bag of calories. According to a study, alcohol lowers inhabitations and increases hunger. Moreover, when you drink, you treat yourself with bar snacks, and this becomes another reason for your increased weight. Solution- Stopping or reducing drinking often go hand in hand with weight loss. 5.Skipping Breakfast If you are skipping breakfast every day or not eating ‘healthy breakfast’ on time, then you are pushing your body to fast more and utilize the energy stored in it. And when your body starts overusing the stored energy, it starts accumulating fat. Solution- Eat breakfast like a king, lunch like a prince and dinner like a pauper. (Added: Thu Jan 10 2019 Hits: 74 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... [>>]